Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$5,110 Mln
P/E Ratio
37.52
P/B Ratio
4.15
Industry P/E
21.29
Debt to Equity
0.16
ROE
0.12 %
ROCE
--
Div. Yield
0.57 %
Book Value
--
EPS
4.27
CFO
$1,283.87 Mln
EBITDA
$1,594.15 Mln
Net Profit
$811.47 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Balchem Corporation (BCPC)
| -4.29 | -4.75 | -3.12 | 12.03 | 6.93 | 10.89 | 11.02 |
|
BSE Sensex*
| 2.79 | 3.89 | 4.78 | 7.71 | 12.12 | 19.71 | 11.44 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|
|
Balchem Corporation (BCPC)
| 9.49 | 21.82 | 46.90 | 13.96 | 30.38 | -2.18 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 106.35 | 75.37 | 43.94 | 1.33 | |
| 1.12 | 9.61 | -- | -16.05 | |
| 0.34 | 15.45 | -- | -358.22 | |
| 58.22 | 1,422.88 | 11.47 | 9.2 |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It... operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey. Address: 5 Paragon Drive, Montvale, NJ, United States, 07645 Read more
Chairman, CEO & President
Mr. Theodore L. Harris
Chairman, CEO & President
Mr. Theodore L. Harris
Headquarters
Montvale, NJ
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Balchem Corporation (BCPC) stood at $ 1,757 Mln as on 31-Mar-25
The share price of Balchem Corporation (BCPC) is $156.01 (NASDAQ) as of 29-Apr-2025 16:00 EDT. Balchem Corporation (BCPC) has given a return of 6.93% in the last 3 years.
Balchem Corporation (BCPC) has a market capitalisation of $ 5,110 Mln as on 29-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Balchem Corporation (BCPC) is 4.15 times as on 29-Apr-2025, a 91% premium to its peers’ median range of 2.17 times.
The P/E ratio of Balchem Corporation (BCPC) is 37.52 times as on 29-Apr-2025, a 76% premium to its peers’ median range of 21.29 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Balchem Corporation (BCPC) and enter the required number of quantities and click on buy to purchase the shares of Balchem Corporation (BCPC).
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey. Address: 5 Paragon Drive, Montvale, NJ, United States, 07645
The CEO & director of Mr. Theodore L. Harris. is Balchem Corporation (BCPC), and CFO & Sr. VP is Mr. Theodore L. Harris.
There is no promoter pledging in Balchem Corporation (BCPC).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1
|
|
|
1
|
|
|
134
|
|
|
8
|
| Balchem Corporation (BCPC) | Ratios |
|---|---|
|
Return on equity(%)
|
11.45
|
|
Operating margin(%)
|
19.86
|
|
Net Margin(%)
|
14.16
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Balchem Corporation (BCPC) was $0 Mln.
$-0.08
(
